Background Allogeneic haematopoietic stem cell transplantation (allo‐HSCT) is an
established treatment option for many malignant and non‐malignant disorders. In the past …

Over the past 30 years, it has been demonstrated that removal of white blood cells from
blood components is effective in preventing some adverse reactions such as febrile non …

Infectious complications after allogeneic haematopoietic stem cell transplantation (allo-HCT)
remain a clinical challenge. This is a guideline provided by the AGIHO (Infectious Diseases …

Together with animal cytomegalovirus, human cytomegalovirus (HCMV), also referred to in
recent literature as human herpes virus 5 (HHV-5), belongs to the Herpesviridae family …

BACKGROUND: Measures to prevent transfusion‐transmitted cytomegalovirus (TT‐CMV)
infection after hematopoietic stem cell transplantation (HSCT) include transfusion of CMV …

BACKGROUND: Human cytomegalovirus (CMV) is considered to latently infect blood cells.
Transfusion‐transmitted infection (TT‐CMV) of immunocompromised patients occurs despite …

Blood component transfusion is integral in the treatment of infants and children by
pediatricians, surgeons, intensivists, and hematologists/oncologists. Technologic advances …

BACKGROUND: Cytomegalovirus (CMV) transfusion‐transmitted disease (TTD) remains a
clinical concern. Universal leukoreduction has become one of the main strategies for the …

We performed a risk–benefit analysis for implementation of pathogen‐inactivated (PI)
apheresis platelets (APs) in the U nited S tates, focusing on the amotosalen/ultraviolet‐A …

Despite advances in the screening of donated blood for infectious agents, the risk of
transmitting viral, bacterial, and protozoal infections, as well as newly emerging diseases …